These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 32562128)

  • 21. Idiopathic Pulmonary Fibrosis: Aging, Mitochondrial Dysfunction, and Cellular Bioenergetics.
    Zank DC; Bueno M; Mora AL; Rojas M
    Front Med (Lausanne); 2018; 5():10. PubMed ID: 29459894
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cellular Senescence in Aging Lungs and Diseases.
    Aghali A; Koloko Ngassie ML; Pabelick CM; Prakash YS
    Cells; 2022 May; 11(11):. PubMed ID: 35681476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mitochondrial dysfunction and cell senescence: deciphering a complex relationship.
    Chapman J; Fielder E; Passos JF
    FEBS Lett; 2019 Jul; 593(13):1566-1579. PubMed ID: 31211858
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Four Corners Sign: A Specific Imaging Feature in Differentiating Systemic Sclerosis-related Interstitial Lung Disease From Idiopathic Pulmonary Fibrosis.
    Walkoff L; White DB; Chung JH; Asante D; Cox CW
    J Thorac Imaging; 2018 May; 33(3):197-203. PubMed ID: 29346191
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Review: Serum biomarkers in idiopathic pulmonary fibrosis and systemic sclerosis associated interstitial lung disease - frontiers and horizons.
    Jee AS; Sahhar J; Youssef P; Bleasel J; Adelstein S; Nguyen M; Corte TJ
    Pharmacol Ther; 2019 Oct; 202():40-52. PubMed ID: 31153954
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nailfold capillaroscopic findings in systemic sclerosis related lung fibrosis and in idiopathic lung fibrosis.
    Corrado A; Carpagnano GE; Gaudio A; Foschino-Barbaro MP; Cantatore FP
    Joint Bone Spine; 2010 Dec; 77(6):570-4. PubMed ID: 20547086
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mitochondria: Are they causal players in cellular senescence?
    Correia-Melo C; Passos JF
    Biochim Biophys Acta; 2015 Nov; 1847(11):1373-9. PubMed ID: 26028303
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanistic links between aging and lung fibrosis.
    Thannickal VJ
    Biogerontology; 2013 Dec; 14(6):609-15. PubMed ID: 23929205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Netrin-1 Regulates Fibrocyte Accumulation in the Decellularized Fibrotic Sclerodermatous Lung Microenvironment and in Bleomycin-Induced Pulmonary Fibrosis.
    Sun H; Zhu Y; Pan H; Chen X; Balestrini JL; Lam TT; Kanyo JE; Eichmann A; Gulati M; Fares WH; Bai H; Feghali-Bostwick CA; Gan Y; Peng X; Moore MW; White ES; Sava P; Gonzalez AL; Cheng Y; Niklason LE; Herzog EL
    Arthritis Rheumatol; 2016 May; 68(5):1251-61. PubMed ID: 26749424
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical Features of Idiopathic Interstitial Pneumonia with Systemic Sclerosis-Related Autoantibody in Comparison with Interstitial Pneumonia with Systemic Sclerosis.
    Yamakawa H; Hagiwara E; Kitamura H; Yamanaka Y; Ikeda S; Sekine A; Baba T; Iso S; Okudela K; Iwasawa T; Takemura T; Kuwano K; Ogura T
    PLoS One; 2016; 11(8):e0161908. PubMed ID: 27564852
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BAL cytokine profile in different interstitial lung diseases: a focus on systemic sclerosis.
    Meloni F; Caporali R; Marone Bianco A; Paschetto E; Morosini M; Fietta AM; Patrizio V; Bobbio-Pallavicini F; Pozzi E; Montecucco C
    Sarcoidosis Vasc Diffuse Lung Dis; 2004 Jun; 21(2):111-8. PubMed ID: 15281432
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IPF lung fibroblasts have a senescent phenotype.
    Álvarez D; Cárdenes N; Sellarés J; Bueno M; Corey C; Hanumanthu VS; Peng Y; D'Cunha H; Sembrat J; Nouraie M; Shanker S; Caufield C; Shiva S; Armanios M; Mora AL; Rojas M
    Am J Physiol Lung Cell Mol Physiol; 2017 Dec; 313(6):L1164-L1173. PubMed ID: 28860144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heme oxygenase-1 induction attenuates senescence in chronic obstructive pulmonary disease lung fibroblasts by protecting against mitochondria dysfunction.
    Even B; Fayad-Kobeissi S; Gagliolo JM; Motterlini R; Boczkowski J; Foresti R; Dagouassat M
    Aging Cell; 2018 Dec; 17(6):e12837. PubMed ID: 30341816
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Impact of HIV- and ART-Induced Mitochondrial Dysfunction in Cellular Senescence and Aging.
    Schank M; Zhao J; Moorman JP; Yao ZQ
    Cells; 2021 Jan; 10(1):. PubMed ID: 33467074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quercetin Enhances Ligand-induced Apoptosis in Senescent Idiopathic Pulmonary Fibrosis Fibroblasts and Reduces Lung Fibrosis In Vivo.
    Hohmann MS; Habiel DM; Coelho AL; Verri WA; Hogaboam CM
    Am J Respir Cell Mol Biol; 2019 Jan; 60(1):28-40. PubMed ID: 30109946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mesenchymal stem cells (MSCs) from scleroderma patients (SSc) preserve their immunomodulatory properties although senescent and normally induce T regulatory cells (Tregs) with a functional phenotype: implications for cellular-based therapy.
    Cipriani P; Di Benedetto P; Liakouli V; Del Papa B; Di Padova M; Di Ianni M; Marrelli A; Alesse E; Giacomelli R
    Clin Exp Immunol; 2013 Aug; 173(2):195-206. PubMed ID: 23607751
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mitochondrial Dysfunction as a Pathogenic Mediator of Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis.
    Ryter SW; Rosas IO; Owen CA; Martinez FJ; Choi ME; Lee CG; Elias JA; Choi AMK
    Ann Am Thorac Soc; 2018 Dec; 15(Suppl 4):S266-S272. PubMed ID: 30759019
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mitochondrial Quality Control in Age-Related Pulmonary Fibrosis.
    Roque W; Cuevas-Mora K; Romero F
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Defining genetic risk factors for scleroderma-associated interstitial lung disease : IRF5 and STAT4 gene variants are associated with scleroderma while STAT4 is protective against scleroderma-associated interstitial lung disease.
    Stock CJW; De Lauretis A; Visca D; Daccord C; Kokosi M; Kouranos V; Margaritopoulos G; George PM; Molyneaux PL; Nihtyanova S; Chua F; Maher TM; Ong V; Abraham DJ; Denton CP; Wells AU; Wain LV; Renzoni EA
    Clin Rheumatol; 2020 Apr; 39(4):1173-1179. PubMed ID: 31916109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ILD-specific health-related quality of life in systemic sclerosis-associated ILD compared with IPF.
    Durheim MT; Hoffmann-Vold AM; Eagan TM; Hovden AO; Lund MB; Bjerke G; Birring SS; Jonassen TM; Johansen OE; Sjåheim T
    BMJ Open Respir Res; 2020 Jun; 7(1):. PubMed ID: 32576559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.